首页> 外文OA文献 >The stress response gene ATF3 is a direct target of the Wnt/β-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells
【2h】

The stress response gene ATF3 is a direct target of the Wnt/β-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells

机译:应激响应基因ATF3是WNT /β-连环蛋白途径的直接靶标,抑制HCT116人结肠直肠癌细胞的侵袭和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aberrant Wnt/β-catenin signaling is implicated in tumorigenesis and the progression of human colorectal cancers, and mutations in the components of the Wnt/β-catenin signaling pathway are observed in the majority of patients. Therefore, extensive studies on the Wnt signaling pathway and its target genes are crucial to understand the molecular events of tumorigenesis and develop an efficacious therapy. In this study, we showed that the stress response gene ATF3 is transcriptionally activated by the binding of β-catenin and TCF4 to the redundant TCF4 site at the proximal promoter region of the ATF3 gene, indicating that ATF3 is a direct target of the Wnt/β-catenin pathway. The loss of function or overexpression studies showed that ATF3 inhibited the migration or invasion of HCT116 cells. The expression of some MMP and TIMP genes and the ratio of MMP2/9 to TIMP3/4 mRNAs was differentially regulated by ATF3. Therefore, though ATF3 is activated downstream of the Wnt/β-catenin pathway, it acts as a negative regulator of the migration and invasion of HCT116 human colon cancer cells exhibiting aberrant Wnt/β-catenin activity. ATF3 is a candidate biomarker and target for human colorectal cancer treatment and prevention.
机译:异常Wnt /β-catenin信号传导与人结肠直肠癌的进展相关,并且在大多数患者中观察到Wnt /β-catenin信号传导途径的组分中的突变。因此,对WNT信号通路及其靶基因的广泛研究对于了解肿瘤发生的分子事件并产生有效的疗法至关重要。在该研究中,我们表明应力响应基因ATF3通过β-连环蛋白和TCF4的结合转录激活ATF3基因的近端启动子区的冗余TCF4位点,表明ATF3是WNT /的直接靶标。 β-连环蛋白途径。功能或过表达研究的丧失表明,ATF3抑制了HCT116细胞的迁移或侵袭。一些MMP和TIMP基因的表达和MMP2 / 9至TIMP3 / 4mRNA的比率通过ATF3差异调节。因此,尽管ATF3在WNT /β-catenin途径的下游被激活,但它用作表现出异常Wnt /β-catenin活性的HCT116人结肠癌细胞的迁移和侵袭的负调节剂。 ATF3是候选生物标志物和人结直肠癌治疗和预防的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号